Development

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Operator, caregiver, and patient safety are at the forefront when selecting the best options and dosage forms.

The expansion will be designed to meet the growing demand for small molecule drug substance development and manufacturing.

Biological and analytical advances enable modern fermentation processes to deliver safe and effective next-generation medicines.

Roche will gain full rights to Inflazome’s portfolio which includes clinical and preclinical orally available small molecule NLRP3 inhibitors.

Risk-based decision-making is impacting all aspects of manufacturing quality from raw material supply to facility inspections. 

Jennifer Markarian is manufacturing editor of BioPharm International.

For certain APIs, including semi-synthetic antibiotics, continuous filtration and drying improves productivity and quality.

CARBOGEN AMCIS has announced significant investments to increase manufacturing capacity in Switzerland and France.

Atomwise’s technology, AtomNet, works to eliminate the barriers of physical screening for small molecule drug discovery.

CordenPharma added a 3000-L solid-phase peptide synthesis vessel to its GMP API facility in Boulder, CO.

HHS announces $354 million in funding for private industry to manufacture generic drugs in the US from raw materials to finished product.